This review centres on the application of various LC-MS and LC-MS-MS t
echniques to the study and solution of practical problems in biomedica
l research. For this purpose it covers a selection of publications in
this area included in the MEDLINE database for the period 1991-mid-199
4. As shown herein, LC-MS is increasingly gaining in importance in the
biomedical field, especially after the revolution brought about by th
e introduction of the new liquid-phase atmospheric pressure ionization
(API) techniques, such as electrospray (ES) and ionspray. The informa
tion in this database shows that thermospray (TS), which clearly domin
ated LC-MS coupling in the 1980s, is on a downward trend relative to t
he more modern API techniques which will certainly dominate this appli
cation field in the present decade. Studies on drug metabolism, therap
eutic drug monitoring and pharmacology have been traditionally carried
out by GC-MS. However, LC-MS has lately been replacing classical GC-M
S techniques in many of these applications. For instance, LC-ES-MS has
greatly facilitated the application of both qualitative and quantitat
ive LC-MS methods to highly polar molecules. This is possible without
the need to resort to elaborate sample handling and derivatization pro
cedures for relatively high-molecular-mass compounds such as drug conj
ugates, biosynthetic and natural peptides and therapeutic proteins obt
ained by recombinant DNA technology, all of them formerly totally inac
cessible to the standard GC-MS or LC-MS methods. With regard to studie
s on metabolism and biochemical phenomena of endogenous compounds, LC-
ES-MS is also becoming very strong in the analysis of structural biopo
lymers such as peptides, proteins, glycoproteins and glycolipids, and
also lower molecular mass compounds such as fatty acids, vitamins, ste
roids and nucleic acids. For example, structural verification of post-
translational modifications in proteins can be efficiently obtained in
the time frame of an LC run and suitable MS methods for the location
of glycopeptide-containing fractions in proteolytic digests of glycopr
oteins have been developed. Interesting examples are also shown of the
use of LC-MS in clinical studies and the determination of biological
markers of disease.